secwatch.observer — SEC 8-K summary
======================================

Issuer:     Organon & Co. (OGN)
CIK:        0001821825
Form:       8-K
Filed at:   2022-05-06T23:59:59+00:00
Accession:  0001104659-22-056906
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organon held Q1 2022 earnings call; financial results not provided in excerpt
-----------------------------------------------------------------------------

- Company held conference call on May 5, 2022 to discuss Q1 2022 results.
- Transcript furnished as Exhibit 99.1, but specific revenue, EPS, or guidance figures are absent from the supplied text.
- Call referenced non-GAAP measures (Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS) and forward-looking statements.
- Full-year 2022 guidance provided on non-GAAP basis due to unpredictability of certain GAAP items.
- Earnings data from the quarter ended March 31, 2022 not available in this excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1821825/000110465922056906/0001104659-22-056906-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1821825/000110465922056906/tm2214364d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-056906

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer